COMPASS Pathways plc
CMPS · Pharmaceutical Preparations · 134.9M shares · +73%/yr ↑ dilution · EDGAR filings ↗
Grade
D42Clinical/early-stage biotech — psilocybin clinical with negative equity and weak liquidity.
Strengths
- Liquidity — current ratio 0.77 (12th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Negative equityNegative book equity (debt/equity -0.60)
- Weak liquidityCurrent ratio 0.77 (<1)
- Chronic dilutionShare count +73%/yr over 4y (dilution, book value/share -102%)
- Strong balance sheetStrong balance sheet — $150M cash & investments
- Notable holderHeld by 5 notable fund(s): ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC +2 more (as of 2026-03-31)
- AccumulatingInstitutional holders rose 8→10 QoQ (2025-12-31→2026-03-31)
Key metrics
Return on equity
544.7%
Return on assets
-136.8%
Debt / equity
-0.6×
Current ratio
0.8×
Tangible book value
-$53M
Cash & investments
$150M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-26 | Nath Kabir | Grant | 175K | — |
| 2026-03-26 | Loxam Teri | Grant | 75K | — |
| 2026-03-11 | Nath Kabir | Tax withheld | 13K | $6.89 |
| 2026-03-11 | Loxam Teri | Tax withheld | 1.8K | $6.89 |
| 2026-03-02 | Loxam Teri | Tax withheld | 4.5K | $7.02 |
| 2026-02-02 | Nath Kabir | Tax withheld | 16K | $6.61 |
| 2025-08-01 | Nath Kabir | Tax withheld | 6.4K | $4.34 |
| 2025-03-11 | Loxam Teri | Grant | 25K | — |
| 2025-03-11 | Nath Kabir | Grant | 92K | — |
| 2025-03-03 | Loxam Teri | Tax withheld | 4.5K | $3.67 |
| 2025-02-03 | Nath Kabir | Tax withheld | 16K | $4.31 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-28 | Shareholder vote | filing ↗ |
| 2026-05-13 | ResultsExhibits | filing ↗ |
| 2026-03-24 | ResultsExhibits | filing ↗ |
| 2026-02-19 | Material agreementReg FDExhibits | filing ↗ |
| 2026-02-17 | Reg FDOtherExhibits | filing ↗ |
| 2026-01-07 | Material agreementDebt obligationExhibits | filing ↗ |
| 2025-11-04 | ResultsExhibits | filing ↗ |
| 2025-10-29 | Exec/director changeExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-28 | 2026-05-27 | 0001816590-26-000046 ↗ |
| 8-K | 2026-05-13 | 2026-05-13 | 0001816590-26-000043 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001816590-26-000042 ↗ |
| 10-K | 2026-03-24 | 2025-12-31 | 0001816590-26-000020 ↗ |
| 8-K | 2026-03-24 | 2026-03-24 | 0001816590-26-000021 ↗ |
| 8-K | 2026-02-19 | 2026-02-18 | 0001628280-26-009501 ↗ |
| 8-K | 2026-02-17 | 2026-02-17 | 0001816590-26-000007 ↗ |
| 8-K | 2026-01-07 | 2026-01-05 | 0001816590-26-000004 ↗ |
| 8-K | 2025-11-04 | 2025-11-04 | 0001816590-25-000149 ↗ |
| 10-Q | 2025-11-04 | 2025-09-30 | 0001816590-25-000150 ↗ |
| 8-K | 2025-10-29 | 2025-10-26 | 0001816590-25-000141 ↗ |
| 8-K | 2025-07-31 | 2025-07-31 | 0001816590-25-000103 ↗ |